Publication:
Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine

Simple item page
dc.contributor.authorWeerawat Manosuthien_US
dc.contributor.authorDavid M. Butleren_US
dc.contributor.authorWasun Chantratitaen_US
dc.contributor.authorChonlaphat Sukasemen_US
dc.contributor.authorDouglas D. Richmanen_US
dc.contributor.authorDavey M. Smithen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of California, San Diegoen_US
dc.contributor.otherVA Medical Centeren_US
dc.date.accessioned2018-09-24T09:06:05Z
dc.date.available2018-09-24T09:06:05Z
dc.date.issued2010-06-01en_US
dc.identifier.citationAIDS Research and Human Retroviruses. Vol.26, No.6 (2010), 609-611en_US
dc.identifier.doi10.1089/aid.2009.0107en_US
dc.identifier.issn08892229en_US
dc.identifier.other2-s2.0-77954203618en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/29232
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77954203618&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titlePatients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirineen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77954203618&origin=inwarden_US

Files

Collections

Scopus 2006-2010